Loading
EuroEyes International Eye Clinic Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Bracklo Marcus Huascar, was filed 15 Jul 2026.
EuroEyes International Eye Clinic Ltd.: what insiders have been doing
EuroEyes International Eye Clinic Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. 3 insiders have disclosed 3 filings since 19 October 2025.
The record shows 2 purchases on the open market worth €336k, made by 2 insiders, against 1 sale by 1 insider. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Jørgensen Jørn Slot filed the largest purchase, €229k, on 8 June 2026. Among those who bought: 2 senior executives.
The clock since the last published purchase (15 July 2026) now reads 102 days. The median gap between a trade and its publication by HKEX is 2 days. Until a filing is published, the market cannot know about the trade.
With 3 filings in twelve months, the company is quieter than the median of 5 filings across the 736 companies we follow on the same exchange. Our records for EuroEyes International Eye Clinic Ltd. go back to 2019, with 144 purchases and 2 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
178
Thresholds
n/a
Buy Volume
€12M
144 ops. · all time
Sell Volume
€3,357
2 ops. · all time
Who traded when
BuySaleJørgensen Jørn Slot6 buys
Jørgensen Jannik Jonas Slot4 buys
Bracklo Marcus Huascar1 buy
Reinstein Dan Zoltan1 sale
Since the insiders bought
- -4.4%Entry HK$2.50 · Close 16 Oct 2026 HK$2.39
- -5.4%Entry HK$2.48 · Close at T+90 HK$2.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,482 of 26,316 companies
68.9
score / 100
Value87
Quality51
FCF yld21%
Earn yld7.6%
EV/EBITDA4.7x
ROE0.3%
Gross mgn41%
Net mgn6.8%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$2.39
Analyst consensus
1 analystsHK$5.80Target HK$5.80(+143%)HK$5.80
Income statement
RevenueHK$796M
Gross profitHK$324.3M41% margin
EBITDAHK$239.4M30% margin
Net incomeHK$54.5M0.3% margin
Valuation
PER (trailing)239.0x
P/Book0.6x
Beta0.29
Balance sheet & cash
Market capHK$762.6M
Total debtHK$410.2M
Free Cash FlowHK$148.1M
Debt / Equity31%
Profitability & ownership
ROE0.3%
ROA2.5%
% insiders66.0%
% institutions2.0%
Last declaration on 15 July 2026
Declarations178 total
403,510 shares@ HK$2.380.13% mcap100.0% of flowShareXHKGHKEX:DA20260715E00226
Canonical exit: 12 Oct 2026 (T+90)
800,000 shares@ HK$2.60100.0% of flowShareXHKGHKEX:DA20260608E00366
Canonical exit: 3 Sept 2026 (T+90)
801,000 sharesShareXHKGHKEX:DA20260416E00121
0ShareXHKGHKEX:DA20250915E00007
100,000 shares@ HK$3.09ShareXHKGHKEX:DA20250729E00084
Canonical exit: 26 Oct 2025 (T+90)
118,000 shares@ HK$2.9642ShareXHKGHKEX:DA20250616E00282
Canonical exit: 11 Sept 2025 (T+90)
616,000 shares@ HK$2.8398ShareXHKGHKEX:DA20250423E00005
Canonical exit: 21 Jul 2025 (T+90)
136,000 shares@ HK$2.8018ShareXHKGHKEX:DA20250411E00071
Canonical exit: 9 Jul 2025 (T+90)
152,000 shares@ HK$2.7871ShareXHKGHKEX:DA20250411E00569
Canonical exit: 9 Jul 2025 (T+90)
42,000 shares@ HK$3.0567ShareXHKGHKEX:DA20250410E00032
Canonical exit: 8 Jul 2025 (T+90)
48,000 shares@ HK$3.0413ShareXHKGHKEX:DA20250409E00494
Canonical exit: 7 Jul 2025 (T+90)
261,000 shares@ HK$3.207ShareXHKGHKEX:DA20250408E00384
Canonical exit: 6 Jul 2025 (T+90)
216,000 shares@ HK$3.3439ShareXHKGHKEX:DA20250403E00295
Canonical exit: 1 Jul 2025 (T+90)
0ShareXHKGHKEX:DA20250228E00284
0ShareXHKGHKEX:DA20250228E00291
0ShareXHKGHKEX:DA20250228E00294
0ShareXHKGHKEX:DA20250228E00297
0ShareXHKGHKEX:DA20250228E00307
0ShareXHKGHKEX:DA20250115E00063
0ShareXHKGHKEX:DA20250115E00065
0ShareXHKGHKEX:DA20250115E00066
0ShareXHKGHKEX:DA20250115E00071
0ShareXHKGHKEX:DA20250115E00059
0ShareXHKGHKEX:DA20240812E00250
0ShareXHKGHKEX:DA20240812E00253
25 of 178 declarations
About EuroEyes International Eye Clinic Ltd.
EuroEyes International Eye Clinic Ltd. is a specialized eye care clinic providing refractive surgery and other ophthalmological treatments. The company is listed on the Hong Kong Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
